{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:14:34Z","timestamp":1761804874335,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:00:00Z","timestamp":1632009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofcardiologycases.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology Cases"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jccase.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T03:52:46Z","timestamp":1632801166000},"page":"199-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of ventricular fibrillation without left ventricular systolic dysfunction induced by trastuzumab emtansine for breast cancer"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0434-3014","authenticated-orcid":false,"given":"Morihiko","family":"Takeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jccase.2021.09.006_bib0001","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1158\/1078-0432.CCR-11-0762","article-title":"Trastuzumab emtansine: A unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer","volume":"17","author":"LoRusso","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jccase.2021.09.006_bib0002","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41416-019-0635-y","article-title":"Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer","volume":"122","author":"Hunter","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jccase.2021.09.006_bib0003","doi-asserted-by":"crossref","first-page":"227","DOI":"10.5114\/aoms.2012.28549","article-title":"Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2-a prospective study","volume":"8","author":"Piotrowski","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jccase.2021.09.006_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111620","article-title":"The mechanistic insights of the arrhythmogenic effect of trastuzumab","volume":"139","author":"Siri-Angkul","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jccase.2021.09.006_bib0005","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1002\/cncr.10854","article-title":"Trastuzumab-associated cardiotoxicity","volume":"95","author":"Keefe","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jccase.2021.09.006_bib0006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejca.2019.11.023","article-title":"Trastuzumab emtansine (T-DM1)-associated cardiotoxicity: Pooled analysis in advanced HER2-positive breast cancer","volume":"126","author":"Pond\u00e9","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jccase.2021.09.006_bib0007","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/annonc\/mdp587","article-title":"Sudden death during adjuvant trastuzumab therapy of breast cancer","volume":"21","author":"Oliveira","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jccase.2021.09.006_bib0008","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1161\/CIRCRESAHA.116.304691","article-title":"Mechanisms of sudden cardiac death: Oxidants and metabolism","volume":"116","author":"Yang","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jccase.2021.09.006_bib0009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joa.2013.12.008","article-title":"Cardiac fibrosis as a determinant of ventricular tachyarrhythmias","volume":"30","author":"Morita","year":"2014","journal-title":"J Arrhythmia"},{"key":"10.1016\/j.jccase.2021.09.006_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.RES.88.3.333","article-title":"Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43","volume":"88","author":"Gutstein","year":"2001","journal-title":"Circ Res"}],"container-title":["Journal of Cardiology Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540921001523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540921001523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:12:05Z","timestamp":1761804725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878540921001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S1878540921001523"],"URL":"https:\/\/doi.org\/10.1016\/j.jccase.2021.09.006","relation":{},"ISSN":["1878-5409"],"issn-type":[{"type":"print","value":"1878-5409"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case of ventricular fibrillation without left ventricular systolic dysfunction induced by trastuzumab emtansine for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology Cases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jccase.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}